Skip to main content

The Leukemia & Lymphoma Society of Canada Names Shelagh Tippet-Fagyas its New President


For Immediate Release Contact:
Andrea Greif
Senior Director, Communications
(914) 821-8958


(White Plains, NY - March 31, 2014) - The Leukemia & Lymphoma Society today announced that its Canadian affiliate, The Leukemia & Lymphoma Society of Canada (LLSC), has named Shelagh Tippet-Fagyas as its new president, effective today. Tippet-Fagyas will lead LLSC in its efforts to find cures and ensure access to therapies for all blood cancer patients in Canada. She will be working with the LLSC Board of Directors, reporting to Gilles Legault, chair of the board, of Montreal, Quebec. "Shelagh has a proven track record of achievement in fund development, strategic planning, and building relationships with potential donors, internal and external stakeholders for national health charities," said Legault. "We look forward to the leadership skills she will bring to LLSC, its board of directors, senior management and staff in her key role."

Most recently Tippet-Fagyas was a principal consultant for UrbanKinistics Consulting Group, where she provided strategy and fundraising counsel in the social service, health, and education sectors. She previously served as the national vice president, revenue development for The Arthritis Society. Her vast executive and senior management background also include experience with the Alzheimer Society of Ontario, the Make-A-Wish Foundation of Canada, Canadian MedicAlert Foundation and ParticipACTION.

Tippet-Fagyas earned her bachelor's degree and master's of science in applied health from the University of Waterloo in Ontario. She is a graduate of the executive business development program, Richard Ivey School of Business, University of Western Ontario, in London, Ontario, and the executive marketing program, Queens University, Kingston, Ontario.


About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (R) (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care. Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit

Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m. ET.


About The Leukemia & Lymphoma Society Canada

The Leukemia & Lymphoma Society of Canada (LLSC) is dedicated to finding cures and better treatments for blood cancers, as well as providing support for patients going through a cancer journey. Headquartered in Toronto, Ontario, there are five regional offices across the country based in Vancouver, Calgary, Toronto, Montreal and Halifax. The mission of The Leukemia & Lymphoma Society of Canada is to cure leukemia, lymphoma, Hodgkin's disease and myleoma and improve the quality of life of patients and their families. LLSC is affiliated with The Leukemia & Lymphoma Society (LLS) in the United States, but is a separate entity and is a registered charity in Canada.